NASDAQ
1.49USD
-0.04 (-2.61%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
57.2M
P/E
—
EPS
—
Beta
0.04
52W range
1.34-3.33
Day range
1.47–1.54
Open
1.52
Prev close
1.53
Volume
101.5K
Avg volume
96.1K
Dividend
0.00
IPO
2022-05-17
https://www.proactiveinvestors.com/companies/news/1095701 · 7/20/2026+0.80
https://www.proactiveinvestors.com/companies/news/1095285 · 7/11/2026+1.00
https://www.proactiveinvestors.com/companies/news/1095122 · 7/8/2026+0.90
https://www.proactiveinvestors.com/companies/news/1090111 · 4/7/2026+0.80
https://www.globenewswire.com/news-release/2026/02/13/3237817/0/en/OKYO-Pharma-Announces-Pricing-of-20-Million-Public-Offering-of-Ordinary-Shares.html · 2/13/2026+0.40
https://www.globenewswire.com/news-release/2026/01/30/3229643/0/en/OKYO-Pharma-Announces-Acceptance-of-Urcosimod-Phase-2-Study-Results-for-Presentation-at-Prestigious-ASCRS-Annual-Meeting.html · 1/30/2026+0.80
https://www.proactiveinvestors.com/companies/news/1085117 · 1/5/2026+0.80
https://www.proactiveinvestors.com/companies/news/1078904 · 9/22/2025+0.80
OKYO Pharma Limited is a biopharmaceutical firm operating at the preclinical stage, dedicated to developing innovative treatments for individuals in the United Kingdom experiencing inflammatory eye conditions and ocular discomfort. Its primary therapeutic candidate is OK-101, specifically designed to address dry eye disease. Additionally, the company is advancing OK-201, an experimental bovine adrenal medulla lipidated-peptide analogue, intended to treat neuropathic ocular pain. Established in 2007, OKYO Pharma Limited maintains its headquarters in London, UK.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
